These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19626587)

  • 1. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
    Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
    Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib.
    Shibayama Y; Nakano K; Maeda H; Taguchi M; Ikeda R; Sugawara M; Iseki K; Takeda Y; Yamada K
    Biol Pharm Bull; 2011; 34(3):433-5. PubMed ID: 21372398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.
    Hu S; Chen Z; Franke R; Orwick S; Zhao M; Rudek MA; Sparreboom A; Baker SD
    Clin Cancer Res; 2009 Oct; 15(19):6062-9. PubMed ID: 19773380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
    Huang Y; Wang Y; Li Y; Guo K; He Y
    J Cancer Res Clin Oncol; 2011 May; 137(5):829-37. PubMed ID: 20809412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
    Leake K; Singhal J; Nagaprashantha LD; Awasthi S; Singhal SS
    PLoS One; 2012; 7(4):e34582. PubMed ID: 22509328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
    Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
    Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance.
    Awasthi YC; Sharma R; Yadav S; Dwivedi S; Sharma A; Awasthi S
    Curr Drug Metab; 2007 May; 8(4):315-23. PubMed ID: 17504221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
    Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
    FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus.
    Nakai Y; Miyake M; Morizawa Y; Hori S; Tatsumi Y; Anai S; Onishi S; Tanaka N; Fujimoto K
    Oncol Rep; 2017 Jan; 37(1):227-234. PubMed ID: 27840968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RLIP76: a target for kidney cancer therapy.
    Singhal SS; Singhal J; Yadav S; Sahu M; Awasthi YC; Awasthi S
    Cancer Res; 2009 May; 69(10):4244-51. PubMed ID: 19417134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity.
    Cheng H; Kari G; Dicker AP; Rodeck U; Koch WJ; Force T
    Circ Res; 2011 Dec; 109(12):1401-9. PubMed ID: 21998323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity toward sorafenib and sunitinib varies between different activating and drug-resistant FLT3-ITD mutations.
    Kancha RK; Grundler R; Peschel C; Duyster J
    Exp Hematol; 2007 Oct; 35(10):1522-6. PubMed ID: 17889720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib.
    Serova M; de Gramont A; Tijeras-Raballand A; Dos Santos C; Riveiro ME; Slimane K; Faivre S; Raymond E
    Cancer Chemother Pharmacol; 2013 May; 71(5):1297-307. PubMed ID: 23479136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of melanoma in a murine model by RLIP76 depletion.
    Singhal SS; Awasthi YC; Awasthi S
    Cancer Res; 2006 Feb; 66(4):2354-60. PubMed ID: 16489041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting p53-null neuroblastomas through RLIP76.
    Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
    Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes.
    Alfaro C; Suarez N; Gonzalez A; Solano S; Erro L; Dubrot J; Palazon A; Hervas-Stubbs S; Gurpide A; Lopez-Picazo JM; Grande-Pulido E; Melero I; Perez-Gracia JL
    Br J Cancer; 2009 Apr; 100(7):1111-9. PubMed ID: 19277038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib, sorafenib and mTOR inhibitors in renal cancer.
    Radulovic S; Bjelogrlic SK
    J BUON; 2007 Sep; 12 Suppl 1():S151-62. PubMed ID: 17935273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RLIP76 Targeted Therapy for Kidney Cancer.
    Singhal SS; Singhal J; Figarola J; Horne D; Awasthi S
    Pharm Res; 2015 Oct; 32(10):3123-36. PubMed ID: 26021465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of Sorafenib and Sunitinib with Enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines.
    Vogl UM; Berger W; Micksche M; Pirker C; Lamm W; Pichelmeyer O; Zielinski CC; Schmidinger M
    Cancer Lett; 2009 May; 277(2):218-26. PubMed ID: 19171421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.